The proposed mechanism involves transdermal absorption , whereby the active compound penetrates the skin's outer layers (stratum corneum) and enters systemic circulation via dermal capillaries
Firstly, chloroplasts actively down-regulate 53 and reduce the processing of RNA encoding genes in photosynthesis-related apparatus 54 , control the routes of chloroplast protein import 55 , phosphorylate chloroplast proteins to inhibit electron transport rate 56,57 , reduce cyclic electron flow (CEF), reduce NPQ, and degrade PSII 15,58 , and finally inhibit photosynthesis to reduce energy obtained by other cellular activities and pathogens and prioritize energy investments
PlexusDx focuses on precision peptide approaches backed by clinical data, helping patients and providers navigate treatment decisions with clarity about what science supports and what remains investigational
Across this body of literature the compound has been described under several names: pentadecapeptide BPC-157, the full Body Protection Compound 157, the early trial designation PL 14736, and the proprietary name Bepecin used in early Croatian pharmaceutical work
However, it is important to describe this as modulation of signaling pathways, not as proven therapeutic effects
Copper peptides are generally safe for most people when used topically, as they don't enter the body to produce systemic effects, but copper peptides might not be appropriate for people with a known allergy or sensitivity to copper